Navigation Links
Pediatric Seizure Study Underway in US to Decide Between Diazepam and Lorazepam

dent reviewers will look for overall trends in study data. If it becomes clear that one drug is more effective at treating seizures, the study will be ended early.

We have consulted a wide range of ethicists, experts and government officials about this study to ensure that we protect patients safety, Dr. Baren said.

The researchers have designed a public information campaign to inform the public about the study in the various communities where it will be performed, Dr. Baren said. They will hold community meetings to provide information about the study to all interested families that might be included in the study. During the meetings they will answer questions and listen to concerns of community members.

Dr. Baren stressed the importance of proper research on all emergency treatments to be sure of their effectiveness. The FDA has emphasized the need to test all drugs used for children so that those used are known to be safe and effective.

The NICHD is funding the study in accordance with the Best Pharmaceuticals for Children Act (BPCA), explained Donald Mattison, Chief of the Obstetric and Pediatric Pharmacology Branch. Under the BPCA, the NIH consults with the U.S. Food and Drug Administration to determine which approved drugs should be prioritized for further testing in children. Dr. Mattison added that roughly two-thirds of drugs prescribed for children have never been specifically tested in children.


'"/>




Page: 1 2 3 4

Related medicine news :

1. Support Services found to Dramatically Impact Pediatric Health Care
2. Pediatricians differ in their opinion of child abuse
3. New Treatment Discovered For Pediatric Cholera
4. Pediatricians Need To Talk To Parents Of Overweight Kids
5. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
6. FDA Accords Priority Review For Pediatric Crohns Disease Drug
7. WHO Updates Outdated Pediatric Growth Charts
8. Pediatricians Resignations Cause Concern at Sale
9. Mental Health Providers Can Be Successfully Located With Pediatricians
10. World’s First Pediatric Laparoscopic Liver Surger
11. Pediatric Dental Care Found Wanting
Post Your Comments:
(Date:12/2/2008)...ay be better spent in other areas, experts say , ...pital rapid response teams, created to prevent car... do not seem to work, a new study finds. , "Man...past decade," said lead researcher Dr. Paul S. Cha...te in Kansas City, Mo. "Earlier studies had shown ...
(Date:12/2/2008)... The Health Story Project was an...t formerly known as “Clinical Document Archi.... CDA4CDT will continue as the label for the techn...ted to Health Level Seven (HL7) for ballot. The ne...s Wire EON) December 2, 2008 -- "Our group h...
(Date:12/2/2008)...by specialists from the USC Viterbi School of Engi...nover times for operating rooms at three Californi...of daytime surgery per year." Because of the succe...clude three more hospitals. , A team from the Vi...d Systems Engineering began work in January, 2008 ...
(Date:12/2/2008)..., WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ -...ill deliver the Keynote address at eHealth Initiat...ng the Pulse of Health IT: A Critical Review of Pr...tions for 2009 and Beyond." , , (Logo: htt...) , , The Keynote speech will begin at 4:30...
Breaking Medicine News(10 mins):Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Operations engineering for more efficient operating rooms 2Health News:Operations engineering for more efficient operating rooms 3
... have died of anthrax in Orissa's tribal dominated...deadly disease in the last two days, health offic...e and Nanda Jani, 35, of Padiguda village under Se...early 500 km from Bhubaneswar, fell to the disease...
...A.P.J. Abdul Kalam Friday urge the nation's doctor...cation at the Post-Graduate Institute of Medical S...ke medical facilities available for village India.... the zeal to treat at least 20 rural patients a ye...
...rdiologist Naresh Trehan has been reinstated as ex...owing an out-of-court settlement ending their week...is Healthcare, which has acquired 90 percent stake...Research Centre (EHIRC), Saturday withdrew the pol...
...e developed by the American Academy of Neurology f...tics are highly effective for treating nervous sys... evidence that prolonged treatment with antibiotic...st following standard therapy. The guideline is pu...
Other Medicine News:Health News:Naresh Trehan Reinstated as Chief of Escorts After Weeklong Row 2Health News:Antibiotics Highly Effective for Treating Lyme Disease 2
(Date:12/1/2008)... today announced the initiation of a Phase 1/2 cli...JAK2 inhibitor, in leading medical centers in Aust...brosis (CIMF). , , The trial is designed t...n patients with CIMF and is expected to enrol up t... assess the safety profile and evaluate the pharma...
(Date:12/1/2008)...y switch that, if turned off, causes lymphatic end...e their identity and become more like blood endoth...ewswire-USNewswire/ -- Scientists at St. Jude Chi...ertain differentiated cell type is so ready to cha...ression of a gene called Prox1 to dissuade it. ...
(Date:12/1/2008)...FirstCall/ -- Following a,Request for Proposal is...ed,third generation smallpox vaccine, Public Wor...he Canadian Department of National Defence, has aw...ery of IMVAMUNE(R). , The Canadian authorit...try,s bio-preparedness programme. , The con...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 1Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 3Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 1Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 2Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 3Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 4Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 5Anesiva Announces May 22 2008 Presentation at Citi Investment Research Global HealthCare Conference 19576 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 2
...TH SAN FRANCISCO, Calif., June 01, 2007,/PRNewswir...y,announced that the company will present data fro...at the 12th Congress of the European,Hematology As...na,Austria. , Presentations will include updated ...rial of SNS-595 in acute leukemias, as,well as cli...
...ich, June 1, 2007-Cytos Biotechnology AG is deligh...esentations of its novel,immunotherapeutic CYT003-...ve clinical results for CYT003-QbG10 were obtained...e XXVI Congress of,the European Academy of Allergo... from June 9-13, 2007 in Göteborg,Sweden. Th...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: